Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

Neurobiology of Aging

Volumn 31, Issue 9, 2010, Pages 1503-1515

  Miklossy, Judith ^a   Qing, Hong ^a   Radenovic, Aleksandra ^b   Kis, Andras ^b   Vileno, Bertrand ^b   Làszló, Forró ^b   Miller, Lisa ^c   Martins, Ralph N ^d   Waeber, Gerard ^e   Mooser, Vincent ^f   Bosman, Fred ^g   Khalili, Kamel ^h   Darbinian, Nune ^h,i   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b EPFL   (Switzerland)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f GLAXOSMITHKLINE   (United States)

^g UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^h TEMPLE UNIVERSITY   (United States)

ⁱ EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Alzheimer's disease; Amylin; Apolipoprotein a; Apolipoprotein E; APP; Beta amyloid; IB1 JIP 1; JNK 1; LPS; Tau; Type 2 diabetes; Ubiquitin

Indexed keywords

AMYLIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN E; CELL PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN IB1; PROTEIN JIP 1; STRESS ACTIVATED PROTEIN KINASE 1; TAU PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ARTICLE; BETA SHEET; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETIC PATIENT; FEMALE; FROZEN SECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULINOMA; MALE; NEUROBLASTOMA CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ISLET; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROSCOPY; SYNCHROTRON INFRARED MICROSPECTROSCOPY; TUMOR CELL LINE; WESTERN BLOTTING;

EID: 77954955774     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.08.019     Document Type: Article

References (51)

1. Alafuzoff, I., Aho, L., Helisalmi, S., Mannermaa, A., Soininen, H., 2008. β-Amyloid deposition in brains of subjects with diabetes. Neuropathol. Appl. Neurobiol, doi:10.1111/j.1365-2990.2008.00948.x.
2. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 2004, 61:661-666.
3. Arvanitakis Z., Schneider J.A., Wilson R.S., Li Y., Arnold S.E., Wang Z., Bennett D.A. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 2006, 67:1960-1965.
4. Asfari M., Janjic D., Meda P., Li G., Halban P.A., Wollheim C.B. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cells. Endocrinology 1992, 130:167-178.
5. Askanas V., Engel W.K., Bilak M., Alvarez R.B., Selkoe D.J. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am. J. Pathol. 1994, 144:177-187.
6. Askanas V., Engel W.K. Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease. Curr. Rheumatol. Rep. 2002, 4:427-433.
7. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., Yhu S., McInnis M.G., Go R.C., Vekrellis K., Selkoe D.J., Saunders A.J., Tanzi R.E. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 2000, 290:2302-2303.
8. Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006, 5:64-74.
9. Burdo, J.R., Chen, Q., Calcutt, N.A., Schubert, D., 2008. The pathological interaction between diabetes and presymptomatic Alzheimer's disease. Neurobiol. Aging (Epub ahead of print), doi:10.1016/j.neurobiolaging.2008.02.010.
10. Charge S.B., Esiri M.M., Bethune C.A., Hansen B.C., Clark A. Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease. J. Pathol. 1996, 179:443-447.
11. Choo L.P., Wetzel D.L., Halliday W.C., Jackson M., LeVine S.M., Mantsch H.H. In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy. Biophys. J. 1996, 71:1672-1679.
12. Cooper G.J.S., Willis A.C., Clark A., Turner R.C., Sim R.B., Reid K.B.M. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:8628-8632.
13. Cooper G.J., Willis A.C., Reid K.B., Clark A., Baker C.A., Turner R.C., Lewis C.E., Morris J.F., Howland K., Rothbard J.B. Diabetes-associated peptide. Lancet 1987, 2(8565):966.
14. Cooper G.J., Leighton B., Dimitriadis G.D., Parry-Billings M., Kowalchuk J.M., Howland K., Rothbard J.B., Willis A.C., Reid K.B. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:7763-7766.
15. Dentchev T., Milam A.H., Lee V.M., Trojanowski J.Q., Dunaief J.L. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol. Vis. 2003, 9:184-190.
16. Goldstein L.E., Muffat J.A., Cherny R.A., Moir R.D., Ericsson M.H., Huang X., Mavros C., Coccia J.A., Faget K.Y., Fitch K.A., Masters C.L., Tanzi R.E., Chylack L.T., Bush A.I. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. Lancet 2003, 361:1258-1265.
17. Grodstein F., Chen J., Wilson R.S., Manson J.E. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 2001, 24:1060-1065.
18. Duggirala R., Blangero J., Almasy L., Arya R., Dyer T.D., Williams K.L., Leach R.J., O'Connell P., Stern M.P. A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am. J. Hum. Genet. 2001, 68:1149-1169.
19. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989, 3:519-526.
20. Grossman H. Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease. C.N.S. Spectr. 2003, 8:815-823.
21. Helbecque N., Abderrahamani A., Meylan L., Riederer B., Mooser V., Miklossy J., Delplanque J., Boutin P., Nicod P., Haefliger J.A., Cottel D., Amouyel P., Froguel P., Waeber G. Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease. Mol. Psychiatry 2003, 4:413-422.
22. Hull R.L., Westermark G.T., Westermark P., Kahn S.E. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J. Clin. Endocrinol. Metab. 2004, 89:3629-3643.
23. Janson J., Laedtke T., Parisi J.E., O'Brien P., Petersen R.C., Butler P.C. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004, 53:474-481.
24. Joachim C.L., Mori H., Selkoe D.J. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature 1989, 341:226-230.
25. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Gordon M., Tan H., Games D., Lieberburg I., Schenk D., Seubert P., McConlogue L. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1550-1555.
26. Kuusisto J., Koivisto K., Mykkanen L., Helkala E.L., Vanhanen M., Hanninen T., Kervinen K., Kesaniemi Y.A., Riekkinen P.J., Laakso M. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 1997, 315:1045-1049.
27. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., Palumbo P.J. The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann. NY Acad. Sci. 1997, 826:422-427.
28. Lopes D.H., Colin C., Degaki T.L., de Sousa A.C., Vieira M.N., Sebollela A., Martinez A.M., Bloch C., Ferreira S.T., Sogayar M.C. Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP). J. Biol. Chem. 2004, 279:42803-42810.
29. Marcovina S.M., Albers J.J., Gabel B., Koschinsky M.L., Gaur V.P. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin. Chem. 1995, 41:246-255.
30. Martin D., Tawadros T., Meylan L., Abderrahmani A., Condorelli D.F., Waeber G., Haefliger J.A. Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. J. Biol. Chem. 2003, 278:53082-53089.
31. Miklossy J., Lepori D., Genton C., Kraftsik R., Pillevuit O., Bosman F.T. Curly fiber and tangle-like structures in the ependyma and the choroid plexus-a pathogenetic relationship with the cortical Alzheimer-type changes?. J. Neuropathol. Exp. Neurol. 1998, 57:104-114.
32. Miklossy J., Taddei K., Martins R., Escher G., Kraftsik R., Pillevuit O., Lepori D., Campiche M. Alzheimer disease: curly fibers and tangles in organs other than brain. J. Neuropathol. Exp. Neurol. 1999, 58:803-814.
33. Miklossy J., Arai T., Guo J.P., Klegeris A., Yu S., McGeer E.G., McGeer P.L. LRRK2 expression in normal and pathologic human brain and in human cell lines. J. Neuropathol. Exp. Neurol. 2006, 65:953-963.
34. Miklossy J., Kis A., Radenovic A., Miller L., Forro L., Martins R., Reiss K., Darbinian N., Darekar P., Mihaly L., Khalili K. Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol. Aging 2006, 27:228-236.
35. Mooser V., Helbecque N., Miklossy J., Marcovina S.M., Nicod P., Amouyel P. Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann. Intern. Med. 2000, 132:533-537.
36. Myers A.J., Goata A.M. The genetics of late-onset Alzheimer's disease. Curr. Opin. Neurol. 2001, 14:433-440.
37. O'Brien J.A., Patrick A.R., Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin. Ther. 2003, 25:1017-1038.
38. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 1999, 53:1937-1942.
39. Panda D., Samuel J.C., Massie M., Feinstein S.C., Wilson L. Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease. Proc. Nat. Acad. Sci. 2003, 100:9548-9553.
40. Peila R., Rodriguez B.L., Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes 2002, 51:1256-1262.
41. Pellet J.B., Haefliger J.A., Staple J.K., Widmann C., Welker E., Hirling H., Bonny C., Nicod P., Catsicas S., Waeber G., Riederer B.M. Spatial, temporal and subcellular localization of islet-brain 1 (IB1), a homologue of JIP-1, in mouse brain. Eur. J. Neurosci. 2000, 12:621-632.
42. Qui W.Q., Folstein M.F. Insulin, insulin-degrading enzyme and amyloid β peptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging 2006, 27:190-198.
43. Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J. Mol. Med. 2004, 82:510-529.
44. Sanke T., Bell G.I., Sample C., Rubenstein A.H., Steiner D.F. An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J. Biol. Chem. 1988, 263:17243-17246.
45. Tanzi R.E., Bertram L. New frontiers in Alzheimer's disease genetics. Neuron 2001, 32:181-184.
46. Voisin T., Lugardon S., Balardy L., Vellas B. Vascular risk factors and Alzheimer's disease. Rev. Med. Intern. 2003, 24(Suppl. 3):288-291.
47. Waeber G., Delplanque J., Bonny C., Mooser V., Steinmann M., Widmann C., Maillard A., Miklossy J., Dina C., Hani E.H., Vionnet N., Nicod P., Boutin P., Froguel P. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat. Genet. 2000, 3:291-295.
48. Westermark P., Wernstedt C., O'Brien T.D., Hayden D.W., Johnson K.H. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am. J. Pathol. 1987, 127:414-417.
49. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 1992, 135:235-238.
50. Xu W.L., Qiu C.X., Wahlin A., Winblad B., Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004, 63:1181-1186.
51. Yasojima K., McGeer E.G., McGeer P.L. High stability of mRNAs postmortem and protocols for their assessment by RT-PCR. Brain Res. Brain Res. Protoc. 2001, 8:212-218.